Randomized, double-blind, active-controlled, multicentre, phase III clinical trial with two stages to assess the safety and efficacy of letibotulinum toxin a vs. onabotulinum toxin a for subjects with moderate to severe crow's feet.

Yoo, K H; Park, S J; Han, H S; Won, C H; Lee, Y W; Kim, B J

Yoo, K H; Park, S J; Han, H S; Won, C H; Lee, Y W; Kim, B J.

Afiliação

Yoo KH; Department of Dermatology, College of Medicine, Chung-Ang University Hospital, Seoul, Korea.
Park SJ; Department of Dermatology, College of Medicine, Chung-Ang University Hospital, Seoul, Korea.
Han HS; Department of Dermatology, College of Medicine, Chung-Ang University Hospital, Seoul, Korea.
Won CH; Department of Dermatology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
Lee YW; Department of Dermatology, College of Medicine, Konkuk University Hospital, Seoul, Korea.
Kim BJ; Department of Dermatology, College of Medicine, Chung-Ang University Hospital, Seoul, Korea.

J Eur Acad Dermatol Venereol ; 35(7): 1587-1594, 2021 Jul.

Article em En | MEDLINE | ID: mdl-33721365

Assuntos

Toxinas Botulínicas Tipo A; Fármacos Neuromusculares; Envelhecimento da Pele; Toxinas Botulínicas Tipo A/efeitos adversos; Método Duplo-Cego; República da Coreia; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento da Pele / Toxinas Botulínicas Tipo A / Fármacos Neuromusculares Tipo de estudo: Clinical_trials País/Região como assunto: Asia Idioma: En Revista: J Eur Acad Dermatol Venereol Assunto da revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google